NRIPESH PRADHAN

Allopathic & Osteopathic Physicians|Internal Medicine|Nephrology EVANSVILLE, IN NPI 1487974267

General Payments — all program years on this page

$1,084.17

  • Category: General Payments
  • Program years: PY2019–2024
  • Record count: 32
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $435.65 across 18 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $435.6518

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2019 $174.832
2020 $99.001
2021 $17.251
2022 $119.422
2023 $238.028
2024 $435.6518

Records — PY2024 (18)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1086163826 Bayer Healthcare Pharmaceuticals Inc. $15.66 05/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104236087 AstraZeneca Pharmaceuticals LP $16.88 11/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104270921 AstraZeneca Pharmaceuticals LP $18.43 01/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117658706 Amgen Inc. $16.71 03/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117658708 Amgen Inc. $20.89 10/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118031402 Boehringer Ingelheim Pharmaceuticals, Inc. $16.54 06/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118031404 Boehringer Ingelheim Pharmaceuticals, Inc. $17.51 08/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118031406 Boehringer Ingelheim Pharmaceuticals, Inc. $28.20 10/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118963317 Otsuka America Pharmaceutical, Inc. $22.00 04/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118963319 Otsuka America Pharmaceutical, Inc. $24.92 06/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118963321 Otsuka America Pharmaceutical, Inc. $27.52 07/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118963323 Otsuka America Pharmaceutical, Inc. $25.86 09/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118963325 Otsuka America Pharmaceutical, Inc. $28.99 10/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1124052175 Vifor Pharma, Inc. $28.62 06/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125857212 Alnylam Pharmaceuticals Inc. $21.10 02/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141511439 CALLIDITAS THERAPEUTICS US INC. $78.84 03/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1149927902 Travere Therapeutics, Inc. $1.27 07/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1149927906 Travere Therapeutics, Inc. $25.71 07/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.